Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Assay:
≥98% (SDS-PAGE)
Form:
solid
Impurities:
≤0.02% fatty acids, ≤3.0% Ash, ≤5% moisture
Quality Level
description
Merck USA index - 14, 8468
assay
≥98% (SDS-PAGE)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
impurities
≤0.02% fatty acids, ≤3.0% Ash, ≤5% moisture
color
off-white to beige
solubility
0.15 M sodium chloride: 10 mg/mL, water: 10 mg/mL
cation traces
heavy metals: ≤10 ppm
foreign activity
endonuclease, none detected, protease ≤0.1 U/mg
shipped in
ambient
storage temp.
2-8°C
General description
Designed for use in serological testing, RIA, and hormone response studies. Suitable for use in Molecular Biology applications, such as Northern and Southern blots. Also useful as a reagent protein standard and as a nutrient in tissue culture where a higher purity BSA is needed.
Preparation Note
Following reconstitution, store in the refrigerator (4°C). 0.1% NaN₃ may be added as a preservative. Stock solutions are stable for up to 3 months at 4°C.
Other Notes
Thomassen, D.G. 1989. In Vitro Cell. Dev. Biol.25, 1046.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
Storage Class
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Roozbeh Khosravi et al.
Bone, 58, 33-41 (2013-10-15)
Diabetes increases the risk of bone fracture. Organic and inorganic bone extracellular matrix components determine bone strength. Previous studies indicate that in diabetes, glycation of collagen causes abnormal arrangements of collagen molecules and fragile bones. Diabetic bone fragility is additionally
Eric E Niederkofler et al.
PloS one, 8(11), e81125-e81125 (2013-11-28)
Insulin-like growth factor 1 (IGF1) is an important biomarker of human growth disorders that is routinely analyzed in clinical laboratories. Mass spectrometry-based workflows offer a viable alternative to standard IGF1 immunoassays, which utilize various pre-analytical preparation strategies. In this work
Daan P Hurkmans et al.
Journal for immunotherapy of cancer, 8(2) (2021-01-12)
Many cancer patients do not obtain clinical benefit from immune checkpoint inhibition. Checkpoint blockade targets T cells, suggesting that tyrosine kinase activity profiling of baseline peripheral blood mononuclear cells may predict clinical outcome. Here a total of 160 patients with